Spero Therapeutics Spero Therapeutics is a biopharmaceutical company developing a pipeline of novel treatments for bacterial infections. | EnClear Therapies EnClear Therapies is a company that develops a medical device designed for the treatment of neurological diseases. | CHF Solutions CHF Solutions (formerly Sunshine Heart) is a biotech company focused on developing an innovative cardiac therapy to treat heart patients. | Respicardia Respicardia develops implantable therapies to improve respiratory and cardiovascular health. | ||
Founding Date | Founding Date 2013 | Founding Date 2018 | Founding Date 2018 | Founding Date 1999 | Founding Date 2006 |
Type | Type Public | Type Private | Type Private | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Cambridge, US HQ | Locations Newburyport, US HQ | Locations HQ | Locations Eden Prairie, US HQ | Locations Hopkins, US HQ |
Employees | Employees 5739% increase | Employees 12 | Employees 563% decrease | Employees 6620% increase | Employees 941% decrease |
Valuation ($) | Valuation ($) 70.8 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 34.5 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $103.8m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $8.9m (FY, 2023) | Revenue (est.) N/A |
Net income | Net income $22.8m (FY, 2023) | Net income N/A | Net income N/A | Net income ($20.2m) (FY, 2023) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 10m (almost 5 years ago) | Latest funding round $ 1.7m (over 4 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 121.5m | Total funding raised $ 12m | Total funding raised $ 1.7m | Total funding raised $ 9m | Total funding raised $ 149.1m |